XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Accumulated Other Comprehensive Income
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. had Accumulated Other Comprehensive Income of $38.82 thousand as of 2019-12-31, per its 10-K filed 2020-06-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2020-06-01
- 2019-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $38.82K.
- 2019-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $70.25K.
- 2019-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $77.61K.
- 2018-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $58.56K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2019-12-31 | $38.82K 10-K · filed 2020-06-01 |
| 2019-09-30 | $70.25K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $77.61K 10-Q · filed 2019-08-15 |
| 2018-12-31 | $58.56K 10-K · filed 2020-06-01 |